Compare HRB & TFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HRB | TFX |
|---|---|---|
| Founded | 1955 | 1943 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.9B | 5.3B |
| IPO Year | 1994 | 1994 |
| Metric | HRB | TFX |
|---|---|---|
| Price | $38.22 | $129.79 |
| Analyst Decision | Sell | Buy |
| Analyst Count | 2 | 8 |
| Target Price | $41.00 | ★ $138.75 |
| AVG Volume (30 Days) | ★ 2.5M | 674.3K |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | ★ 5.34% | 1.02% |
| EPS Growth | ★ 6.55 | N/A |
| EPS | ★ 3.38 | N/A |
| Revenue | ★ $3,159,931,000.00 | $1,992,713,000.00 |
| Revenue This Year | $4.39 | $15.97 |
| Revenue Next Year | $3.21 | $5.15 |
| P/E Ratio | $11.09 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $28.16 | $100.18 |
| 52 Week High | $58.21 | $139.67 |
| Indicator | HRB | TFX |
|---|---|---|
| Relative Strength Index (RSI) | 57.41 | 51.87 |
| Support Level | $29.24 | $117.57 |
| Resistance Level | $39.84 | $134.98 |
| Average True Range (ATR) | 1.36 | 3.60 |
| MACD | -0.26 | -0.43 |
| Stochastic Oscillator | 38.26 | 49.04 |
H&R Block Inc provides income tax return preparation services, digital do-it-yourself tax solutions, and other services related to income tax preparation to the general public in the United States, Canada, and Australia. The company mainly prepares tax returns for customers within the United States through its company-owned offices, franchise locations, and online tax software. The vast majority of H&R Block's offices are located in the U.S. The company derives the majority of its total revenue from the U.S. assisted tax preparation fees. Revenue from franchise and product royalties and digital do-it-yourself tax solutions is also relatively.
Teleflex Inc is a provider of medical technology products focused on enhancing clinical benefits, improving patient and provider safety and reducing total procedural costs. It designs, develops, manufactures and supply medical devices used by hospitals and healthcare providers supporting high-acuity emergent procedures. The company has three reportable segments: Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). It derives maximum revenue from Americas. Its products includes: Anaesthesia, Emergency Medicine, Interventional Cardiology/Radiology, Interventional Urology - UroLift System, Surgery, Urology, and Vascular Access.